Patents by Inventor Farhan Abdel Karim Mohammad AL HUSBAN

Farhan Abdel Karim Mohammad AL HUSBAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL FORMULATIONS
    Publication number: 20210330665
    Abstract: The present specification relates to pharmaceutical formulations comprising N-(1-(3-fluoropropyl)azetidin-3-yl)-6-((6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)pyridin-3-amine, microcrystalline cellulose (MCC) and dicalcium phosphate anhydrous (DCPA), for example tablets with immediate release properties.
    Type: Application
    Filed: April 22, 2021
    Publication date: October 28, 2021
    Inventor: Farhan Abdel Karim Mohammad AL HUSBAN
  • Orally disintegrating tablets
    Patent number: 10729655
    Abstract: The present invention relates to rapidly disintegrating oral dosage forms, more particularly to rapidly disintegrating tablets containing (1S,2S,3R,5S)-3-[7-{[1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylthio)-3H-[1,2,3]-triazolo[4,5-d]pyrimidin-3-yl]-5 5-(2-hydroxyethoxy)cyclopentane-1,2-diol and a disintegrating excipient. Blister packs suitable for use with the rapidly disintegrating oral dosage form are also disclosed.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: August 4, 2020
    Assignee: AstraZeneca AB
    Inventors: Farhan Abdel Karim Mohammad Al Husban, Lars Håkan Christer Glad, Jenny Malin Christina Hallstein, Andrea Jane Moir, Michael Peter Thompson
  • ORALLY DISINTEGRATING TABLETS
    Publication number: 20190117577
    Abstract: The present invention relates to rapidly disintegrating oral dosage forms, more particularly to rapidly disintegrating tablets containing (1S ,2S ,3R,5S)-3-[7-{[1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylthio)-3H-[1,2,3]-triazolo[4,5-d]pyrimidin-3-yl]-55-(2-hydroxyethoxy)cyclopentane-1,2-diol and a disintegrating excipient. Blister packs suitable for use with the rapidly disintegrating oral dosage form are also disclosed.
    Type: Application
    Filed: April 20, 2017
    Publication date: April 25, 2019
    Inventors: Farhan Abdel Karim Mohammad AL HUSBAN, Lars Håkan Christer GLAD, Jenny Malin Christina HALLSTEIN, Andrea Jane MOIR, Michael Peter THOMPSON